Type of rheumatoid arthritis medication may be associated with increased risk for shingles
Tuesday, February 17, 2009 - 17:07
in Health & Medicine
Use of certain medications known as monoclonal anti- tumor necrosis factor α (TNF-α) antibodies for the treatment of rheumatoid arthritis appears to be associated with an increased risk for herpes zoster (shingles), the painful infection characterized by blisters, according to a study in the February 18 issue of JAMA.
Read the whole article on Physorg
More from Physorg
Related
- Type of rheumatoid arthritis medication may be associated with increased risk for shinglesTue, 17 Feb 2009, 17:07:55 EST
- Anti-tumor necrosis factor treatment does not increase cancer Risk in RA patientsThu, 29 Oct 2009, 1:23:53 EDT
- Risk of tuberculosis from arthritis medication examinedTue, 30 Jun 2009, 18:42:30 EDT
- New drug shows promising results for psoriatic arthritisTue, 7 Apr 2009, 13:29:37 EDT
- Working environment is 1 cause of rheumatoid arthritisWed, 24 Sep 2008, 11:08:40 EDT